MHC will be closed for the Holidays on December 24-25, 2024, and December 31, 2024, through January 1, 2025. Insulated pharmaceuticals will be shipped through December 18, 2024. Standard two-day shipping will resume on January 6, 2025. For inquiries about overnight shipments, please reach out to your representative.
Use this bar to show information about your cookie policy.
Description
Product Description:
Apraclonidine Ophthalmic Solution, 0.5% as base is indicated for short-term adjunctive therapy in patients on maximally tolerated medical therapy who require additional IOP reduction. Patients on maximally tolerated medical therapy who are treated with Apraclonidine Ophthalmic Solution to delay surgery should have frequent followup examinations and treatment should be discontinued if the intraocular pressure rises significantly.
Specifications and More Data:
Compare to:
Iopidine .5%
Rx\OTC
Rx (You must have a state license to purchase this product)
